SWA
SFMG Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.79M | Buy |
9,337
+2,925
| +46% | +$1.19M | 0.28% | 47 |
|
|
2025
Q1 | $3.19M | Buy |
6,412
+325
| +5% | +$162K | 0.25% | 53 |
|
|
2024
Q4 | $3.17M | Sell |
6,087
-73
| -1% | -$38K | 0.25% | 51 |
|
|
2024
Q3 | $3.81M | Buy |
6,160
+111
| +2% | +$68.7K | 0.31% | 39 |
|
|
2024
Q2 | $3.34M | Buy |
6,049
+213
| +4% | +$118K | 0.29% | 47 |
|
|
2024
Q1 | $3.39M | Buy |
5,836
+118
| +2% | +$68.6K | 0.29% | 47 |
|
|
2023
Q4 | $3.03M | Buy |
5,718
+66
| +1% | +$35K | 0.28% | 47 |
|
|
2023
Q3 | $2.86M | Buy |
5,652
+131
| +2% | +$66.3K | 0.29% | 49 |
|
|
2023
Q2 | $2.88M | Buy |
5,521
+222
| +4% | +$116K | 0.3% | 49 |
|
|
2023
Q1 | $3.05M | Buy |
5,299
+98
| +2% | +$56.5K | 0.33% | 44 |
|
|
2022
Q4 | $2.86M | Buy |
5,201
+131
| +3% | +$72.1K | 0.32% | 45 |
|
|
2022
Q3 | $2.54M | Buy |
5,070
+620
| +14% | +$310K | 0.3% | 46 |
|
|
2022
Q2 | $2.42M | Buy |
4,450
+349
| +9% | +$190K | 0.28% | 52 |
|
|
2022
Q1 | $2.42M | Buy |
4,101
+493
| +14% | +$291K | 0.24% | 57 |
|
|
2021
Q4 | $2.41M | Buy |
3,608
+426
| +13% | +$284K | 0.23% | 57 |
|
|
2021
Q3 | $1.82M | Buy |
3,182
+671
| +27% | +$383K | 0.2% | 66 |
|
|
2021
Q2 | $1.27M | Buy |
2,511
+480
| +24% | +$242K | 0.14% | 78 |
|
|
2021
Q1 | $927K | Buy |
2,031
+1,449
| +249% | +$661K | 0.11% | 96 |
|
|
2020
Q4 | $271K | Buy |
+582
| New | +$271K | 0.03% | 177 |
|